
RVLPQ
Healthcare · Biotechnology · $1,114 market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2023
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 14, 2026 | Time not confirmed | — | 0.00 | — |
| Mar 16, 2026 | Time not confirmed | — | 0.00 | — |
| Nov 28, 2025 | Time not confirmed | — | 0.00 | — |
| Aug 29, 2025 | Time not confirmed | — | 0.00 | — |
| May 30, 2025 | Time not confirmed | — | 0.00 | — |
| Mar 17, 2025 | Time not confirmed | -0.02 | -0.24 | -1100.0% |
| Nov 29, 2024 | Time not confirmed | -0.04 | 0.00 | +100.0% |
| Aug 12, 2024 | Time not confirmed | -0.04 | 0.00 | +100.0% |
| May 9, 2024 | Time not confirmed | -0.06 | 0.00 | +100.0% |
| Mar 27, 2024 | Time not confirmed | -0.11 | 0.00 | +100.0% |
| Nov 15, 2023 | Time not confirmed | -0.11 | 0.00 | +100.0% |
| Aug 14, 2023 | Before the open | -0.10 | -0.08 | +20.0% |
| May 11, 2023 | Time not confirmed | -0.12 | -0.12 |
RVL Pharmaceuticals plc operates as a specialty pharmaceutical company in the United States, Argentina, and Hungary. It focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the…
| 0.0% |
| Mar 20, 2023 | After the close | -0.17 | -0.19 | -11.8% |
| Nov 10, 2022 | After the close | -0.15 | -0.13 | +13.3% |
| Aug 11, 2022 | Before the open | -0.26 | -0.15 | +42.3% |
| May 12, 2022 | Time not confirmed | -0.08 | -0.08 | 0.0% |
| Mar 30, 2022 | After the close | -0.31 | -0.22 | +29.0% |
| Nov 15, 2021 | After the close | -0.32 | -0.26 | +18.8% |
| Aug 16, 2021 | After the close | -0.15 | -0.35 | -133.3% |
| May 13, 2021 | After the close | -0.23 | -0.21 | +8.7% |
| Mar 30, 2021 | Time not confirmed | -0.88 | -0.88 | 0.0% |
| Nov 10, 2020 | After the close | -0.21 | 0.21 | +200.0% |
| Aug 11, 2020 | After the close | -0.15 | -0.16 | -6.7% |
| May 12, 2020 | After the close | -0.16 | 0.01 | +106.3% |
| Mar 18, 2020 | Time not confirmed | -0.51 | -0.51 | 0.0% |
| Nov 14, 2019 | After the close | -0.17 | 0.01 | +105.9% |
| Aug 8, 2019 | After the close | -0.10 | -0.18 | -80.0% |
| May 9, 2019 | After the close | -0.09 | -0.12 | -33.3% |
| Mar 27, 2019 | Time not confirmed | 0.03 | -2.37 | -8000.0% |
| Oct 1, 2018 | Time not confirmed | 5.08 | -0.88 | -117.3% |
| Aug 29, 2018 | Time not confirmed | — | 0.17 | — |